Showing results (301-310 of 419) with videos related to

Sort By:
Pageof 42
Advances in Experimental Medicine and Biology|January 1, 1996
A phase II trial of autologous bone marrow transplantation (ABMT) in acute leukemia with edelfosine purged bone marrowW R Vogler, W E Berdel, R B Geller, et al.
Leukemia|May 10, 2000
Immune and hematopoietic reconstitution after transplantation of cord blood progenitor cells: case report and review of the literatureR Elhasid, M W Ben Arush, S Pollack, et al.
Cancer|February 19, 1999
Mitoxantrone, etoposide, and cytarabine plus cyclosporine for patients with relapsed or refractory acute myeloid leukemia: an Eastern Cooperative Oncology Group pilot studyM S Tallman, S Lee, B I Sikic, et al.
Pediatric Hematology and Oncology|February 9, 2002
Therapeutic monitoring of busulfan in pediatric bone marrow transplantationN Krivoy, E Hoffer, A Tabak, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 29, 1998
Determination and validation of a predictive model for Clostridium difficile diarrhea in hospitalized oncology patientsK Hornbuckle, A Chak, H M Lazarus, et al.
Cytotherapy|May 25, 2002
Tumor cell depletion of peripheral blood progenitor cells using positive and positive/negative selection in metastatic breast cancerR A Preti, H M Lazarus, J Winter, et al.
American Journal of Clinical Oncology|December 1, 1991
Treatment of advanced refractory lymphomas with a combination of carmustine, bleomycin, teniposide, dexamethasone, and cisplatin (the BBVDD regimen). An ECOG pilot studyA S Spiers, J H Weens, J M Rowe, et al.
Leukemia|August 15, 2000
Duration of second complete remission compared with first complete remission in patients with acute myeloid leukemia. Eastern Cooperative Oncology GroupS Lee, M S Tallman, M M Oken, et al.
Bone Marrow Transplantation|June 6, 2006
Lack of isohemagglutinin production following minor ABO incompatible unrelated HLA mismatched umbilical cord blood transplantationM Snell, C Chau, D Hendrix, et al.
Blood|June 1, 1985
High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: a pilot studyS N Wolff, J Marion, R S Stein, et al.
Pageof 42